EA exerts therapeutic effects on persistent itch and skin inflammation in AD mice by activating CB2R, thereby inhibiting mast cell and CD4 + T cell proliferation and the expression of associated inflammatory factors, as well as downstream ERK phosphorylation (Fig. 8). This evidence concerns the gene CD4 and dermatitis.